Funnel-web spider venom spawns heart attack and stroke drug

Australian Community Media

Mark Smythe says funnel-web venom is being trialled on patients to treat heart attacks and stroke. Footage supplied by University of Queensland via AAP

Transcript

00:00So Infensa has developed IB409, which is a molecule that we are commercialising for heart

00:08attack and stroke.

00:10So it is currently in phase 1 clinical trials, looking at the safety of IB409 in normal healthy

00:16volunteers.

00:17We'll get some idea of dose, whether the dose is suitable for us to dose phase 2, and in

00:21phase 2 we'll look at the ability of IB409 to protect heart tissue during a heart attack.

00:28I find treatments for heart attack and stroke about restoring blood flow, not about protecting

00:33the heart tissue.

00:35IB409 is unique, it actually is cardio protective.

00:39It actually hits one of the root causes of tissue damage and prevents heart damage during a heart

00:45attack or stroke.

00:46There are no drugs on the market that do such a thing, prevent that heart damage during a

00:50heart attack or stroke.

Category

Transcript

Be the first to comment

Recommended